With continued long-term treatment, 28.6% of the patients were free of myoclonic seizures for at least 6 months and 21.0% were free of myoclonic seizures for at least 1 year.
Pikaajalise jätkuravi kestel ei esinenud 28, 6% patsientidest müokloonilisi krampe vähemalt 6 kuu ja 21, 0% vähemalt 1 aasta jooksul.